ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,026,000 | +60.3% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,264,000 | -10.4% | 107,400 | +3.9% | 0.00% | 0.0% |
| Q1 2019 | $1,411,000 | -45.7% | 103,400 | -59.2% | 0.00% | -50.0% |
| Q4 2018 | $2,597,000 | +50.8% | 253,400 | +145.1% | 0.00% | +100.0% |
| Q3 2018 | $1,722,000 | +5.4% | 103,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,634,000 | +51.2% | 103,400 | +21.5% | 0.00% | 0.0% |
| Q1 2018 | $1,081,000 | -48.3% | 85,106 | -53.4% | 0.00% | 0.0% |
| Q4 2017 | $2,092,000 | +158.3% | 182,740 | +176.3% | 0.00% | 0.0% |
| Q3 2017 | $810,000 | -95.2% | 66,140 | -95.5% | 0.00% | -92.3% |
| Q2 2017 | $16,930,000 | -43.1% | 1,478,616 | +3.4% | 0.01% | -45.8% |
| Q1 2017 | $29,740,000 | -7.7% | 1,429,799 | -7.7% | 0.02% | -11.1% |
| Q4 2016 | $32,228,000 | -25.9% | 1,549,442 | +16.7% | 0.03% | -27.0% |
| Q3 2016 | $43,504,000 | +27.3% | 1,327,562 | -3.0% | 0.04% | +27.6% |
| Q2 2016 | $34,177,000 | -12.4% | 1,368,718 | -14.1% | 0.03% | -12.1% |
| Q1 2016 | $39,010,000 | -20.0% | 1,592,907 | +7.8% | 0.03% | -21.4% |
| Q4 2015 | $48,790,000 | +0.6% | 1,477,129 | -0.2% | 0.04% | 0.0% |
| Q3 2015 | $48,502,000 | -30.6% | 1,480,526 | +12.2% | 0.04% | -27.6% |
| Q2 2015 | $69,926,000 | +82.9% | 1,320,109 | -0.3% | 0.06% | +87.1% |
| Q1 2015 | $38,222,000 | +33724.8% | 1,324,381 | +33858.5% | 0.03% | – |
| Q4 2014 | $113,000 | +71.2% | 3,900 | -25.0% | 0.00% | – |
| Q3 2014 | $66,000 | -47.6% | 5,200 | -17.5% | 0.00% | – |
| Q2 2014 | $126,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |